Binder Brant - Aug 8, 2023 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role: Former director
Signature: /s/ Brant Binder
Stock symbol: ERNA
Transactions as of: Aug 8, 2023
Transactions value $: $0
Form type: 4
Date filed: 8/10/2023, 05:00 PM
Previous filing: Jul 18, 2023

Binder Brant is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Reporting person resigned as a director of the Issuer on August 8, 2023. As a result, Reporting Person is no longer subject to Section 16 reporting in connection with the securities of the Issuer.